newsfilter
← Latest News
Earnings Call Transcripts·

STIFEL 2026 VIRTUAL CARDIOMETABOLIC FORUM - BIOAGE LABS INC

Hi, good afternoon, and welcome to the BioAge session. It's our pleasure to have B.J. Sullivan, Chief Strategy Officer of the company. BioAGE is developing an NLRP3 inhibitor, which has CNS penetrant properties for both

Company
BIOAGE LABS INC
Keywords
BIOAGE LABS INC